Immunotherapy in Malignant Pleural Mesothelioma

The only registered systemic treatment for malignant pleural mesothelioma (MPM) is platinum based chemotherapy combined with pemetrexed, with or without bevacizumab. Immunotherapy did seem active in small phase II trials. In this review, we will highlight the most important immunotherapy-based resea...

Descripción completa

Detalles Bibliográficos
Autores principales: de Gooijer, Cornedine J., Borm, Frank J., Scherpereel, Arnaud, Baas, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047444/
https://www.ncbi.nlm.nih.gov/pubmed/32154179
http://dx.doi.org/10.3389/fonc.2020.00187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047444/
https://www.ncbi.nlm.nih.gov/pubmed/32154179
http://dx.doi.org/10.3389/fonc.2020.00187

Ejemplares similares